Form 4 for CUE Cue Biopharma, Inc.
Accepted 2022-06-16 00:00:00 ET · period of report 2022-06-14 · accession 0001209191-22-037394 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-16 | 2022-06-14 | CUE | Gray Cameron | Dir | X - OptEx | $2.70 | +61.1K | 738.6K | +9% | +$165.0K |
| D | 2022-06-16 | 2022-06-14 | CUE | Gray Cameron | Dir | F - Tax | $3.20 | -51.6K | 687.0K | -7% | -$165.0K |
| D | 2022-06-16 | 2022-06-14 | CUE | Gray Cameron | Dir | X - OptEx | $0.00 | -61.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-14 | X | A | 61,111 | $2.70 | 738,611 | D | — | — | |
| 2 | Common | Common Stock | 2022-06-14 | F | D | 51,562 | $3.20 | 687,049 | D | — | — | |
| 3 | Derivative | Warrants | 2022-06-14 | X | D | 61,111 | $0.00 | 0 | D | $2.70 · 2015-06-15 to 2022-06-15 | 61,111 Common Stock |